MONALIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

MONALIZUMAB

Official Name

English

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS KLRC1 (KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY C MEMBER 1, NKG2-A, NKG2A, CD159A, CD94)), HUMANIZED MONOCLONAL ANTIBODY

Systematic Name

English

Monalizumab [WHO-DD]

Common Name

English

NN-8765

Code

English

NN8765

Code

English

IPH-2201

Common Name

English

IPH2201

Code

English

IPH-2201 (ANTI-NKG2A)

Code

English

monalizumab [INN]

Common Name

English

NN8765-3658

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C129822

Created by admin on Sat Dec 16 09:09:29 GMT 2023 , Edited by admin on Sat Dec 16 09:09:29 GMT 2023

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 09:09:29 GMT 2023 , Edited by admin on Sat Dec 16 09:09:29 GMT 2023

Code System Code Type Description

INN

10113

Created by admin on Sat Dec 16 09:09:29 GMT 2023 , Edited by admin on Sat Dec 16 09:09:29 GMT 2023

PRIMARY

FDA UNII

3ZXZ2V0588

Created by admin on Sat Dec 16 09:09:29 GMT 2023 , Edited by admin on Sat Dec 16 09:09:29 GMT 2023

PRIMARY

NCI_THESAURUS

C120208

Created by admin on Sat Dec 16 09:09:29 GMT 2023 , Edited by admin on Sat Dec 16 09:09:29 GMT 2023

PRIMARY

EVMPD

SUB180109

Created by admin on Sat Dec 16 09:09:29 GMT 2023 , Edited by admin on Sat Dec 16 09:09:29 GMT 2023

PRIMARY

WIKIPEDIA

Monalizumab

Created by admin on Sat Dec 16 09:09:29 GMT 2023 , Edited by admin on Sat Dec 16 09:09:29 GMT 2023

PRIMARY

CAS

1228763-95-8

Created by admin on Sat Dec 16 09:09:29 GMT 2023 , Edited by admin on Sat Dec 16 09:09:29 GMT 2023

PRIMARY

DRUG BANK

DB12824

Created by admin on Sat Dec 16 09:09:29 GMT 2023 , Edited by admin on Sat Dec 16 09:09:29 GMT 2023

PRIMARY

ACTIVE MOIETY


					3ZXZ2V0588